An essential role for antibody in neutrophil and eosinophil recruitment to the cornea: B cell-deficient (μMT) mice fail to develop Th2-dependent, helminth-mediated keratitis

Journal of Immunology

Volumn 163, Issue 9, 1999, Pages 4970-4975

  Hall, Laurie R ^a   Lass, Jonathan H ^a   Diaconu, Eugenia ^a   Strine, Ellen R ^a   Pearlman, Eric ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CYTOKINE; IMMUNOGLOBULIN G;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORNEA; CYTOKINE PRODUCTION; EOSINOPHIL; FEMALE; HELPER CELL; IMMUNOGLOBULIN PRODUCTION; KERATITIS; MALE; MOUSE; NEUTROPHIL; NONHUMAN; ONCHOCERCA VOLVULUS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; B-LYMPHOCYTES; CHEMOTAXIS, LEUKOCYTE; CORNEA; EOSINOPHILIA; EOSINOPHILS; IMMUNE SERA; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN MU-CHAINS; INJECTIONS; KERATITIS; LYMPHOPENIA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHIL INFILTRATION; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS, OCULAR; STROMAL CELLS; TH2 CELLS;

EID: 0032709777     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Hall, L. R., and E. Pearlman. 1999. Pathogenesis of onchocercal keratitis (river blindness). Clin. Microbiol. Rev. 12:445.
2. Pearlman, E. 1997. Immunopathology of onchocerciasis: a role for eosinophils in onchocercal dermatitis and keratitis. Chem. Immunol. 66:26.
3. Abiose, A. 1998. Onchocercal eye disease and the impact of Mectizan treatment. Ann. Trop. Med. Parasitol. 92:S11.
4. Pearlman, E., J. Lass, D. Bardenstein, M. Kopf, F. Hazlett, E. Diaconu, and J. Kazura. 1995. Interleukin 4 and T helper type 2 cells are required for development of experimental onchocercal keratitis (river blindness). J. Exp. Med. 182: 931.
5. Pearlman, E., L. R. Hall, A. W. Higgins, D. S. Bardenstein, E. Diaconu, F. E. Hazlett Jr., J. L. Albright, J. W. Kazura, and J. H. Lass. 1998. The role of eosinophils and neutrophils in helminth-induced keratitis. Invest. Ophthalmol. Vis. Sci. 39:1176.
6. Pearlman, E., J. Lass, D. Bardenstein, E. Diaconu, F. J. Hazlett, J. Albright, A. Higgins, and J. Kazura. 1996. Onchocerca volvulus-mediated keratitis: cytokine production by IL-4-deficient mice. Exp. Parasitol. 84:274.
7. Pearlman, E., J. H. Lass, D. S. Bardenstein, F. E. Hazlett, J. L. Albright, G. Diaconu, and J. W. Kazura. 1997. IL-12 exacerbates helminth-mediated corneal pathology by augmenting cell recruitment and chemokine expression. J. Immunol. 158:827.
8. Kitamura, D., and K. Rajewsky. 1992. Targeted disruption of μ chain membrane exon causes loss of heavy-chain allelic exclusion. Nature 356:154.
9. Tang, Q., W. Chen, and R. Hendricks. 1997. Proinflammatory functions of IL-2 in herpes simplex virus corneal infection. J. Immunol. 158:1275.
10. Chakravarti, B., J. H. Lass, E. Diaconu, D. S. Bardenstein, C. E. Roy, T. A. Herring, D. N. Chakravarti, and B. M. Greene. 1993. Immune-mediated Onchocerca volvulus sclerosing keratins in the mouse. Exp. Eye Res. 57:21.
11. + T cells into cornea during development of Onchocerca volvulus-induced experimental sclerosing keratitis in mice. Cell. Immunol. 159:306.
12. Gallin, M. Y., D. Murray, J. H. Lass, H. E. Grossniklaus, and B. M. Greene. 1988. Experimental interstitial keratitis induced by Onchocerca volvulus antigens. Arch. Ophthalmol. 106:1447.
13. Hjelmstrom, P., A. E. Juedes, J. Fjell, and N. H. Ruddle. 1998. B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprolein sensitization. J. Immunol. 161:4480.
14. Brown, D. R., and S. L. Reiner. 1999. Polarized helper-T-cell responses against Leishmania major in the absence of B cells. Infect. Immun. 67:266.
15. Korsgren, M., J. S. Erjefalt, O. Korsgren, F. Sundler, and C. G. Persson. 1997. Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice. J. Exp. Med. 185:885.
16. Wolf, S. D., B. N. Dittel, F. Hardardottir, and C. A. Janeway Jr. 1996. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 184:2271.
17. + T cell-mediated granulomatous pathology in schistosomiasis is downregulated by a B cell-dependent mechanism requiring Fc receptor signaling. J. Exp. Med. 187:619.
18. Hamelmann, E., A. T. Vella, A. Oshiba, J. W. Kappler, P. Marrack, and E. W. Gelfand. 1997. Allergic airway sensitization induces T cell activation but not airway hyperresponsiveness in B cell-deficient mice. Proc. Natl. Acad. Sci. USA 94:1350.
19. Allansmith, M. R., and B. H. McClellan. 1975. Immunoglobulins in the human cornea. Am. J. Ophthalmol. 80:123.
20. Stock, E. L., and S. B. Aronson. 1970. Corneal immune globulin distribution. Arch. Ophthalmol. 84:355.
21. Rothenberg, M. E., J. A. MacLean, E. Pearlman, and P. Leder. 1997. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J. Exp. Med. 185:785.
22. Garcia-Zepeda, E. A., M. E. Rothenberg, R. O. Ownbey, J. Celestin, P. Leder, and A. D. Luster. 1996. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat. Med. 2:449.
23. Nakajima, H., G. J. Gleich, and H. Kita. 1996. Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils. J. Immunol. 156:4859.
24. Tumpey, T., H. Cheng, D. Cook, O. Smithies, J. Oakes, and R. Lausch. 1998. Absence of macrophage inflammatory protein-1α prevents the development of blinding herpes stromal keratitis. J. Virol. 72:3705.
25. Tumpey, T., H. Cheng, X. Van, J. Oakes, and R. Lausch. 1998. Chemokine synthesis in the HSV-1-infected comea and its suppression by interleukin-10. J. Leukocyte Biol. 63:486.
26. Morita, E., J. M. Schroder, and E. Christophers. 1989. Differential sensitivities of purified human eosinophils and neutrophils to defined chemotaxins. Scand. J. Immunol. 29:709.
27. Ward, P. A., and L. J. Newman. 1969. A neutrophil chemotactic factor from human C′5. J. Immunol. 102:93.
28. Wardlaw, A. J., R. Moqbel, O. Cromwell, and A. B. Kay. 1986. Platelet-activating factor: a potent chemotactic and chemokinetic factor for human eosinophils. J. Chem. Invest. 78:1701.
29. Daffern, P. J., P. H. Pfeifer, J. A. Ember, and T. E. Hugli. 1995. C3a is a chemotaxin for human eosinophils but not for neutrophils: C3a stimulation of neutrophils is secondary to eosinophil activation. J. Exp. Med. 181:2119.
30. Mondino, B. J., and K. J. Brady. 1981. Distribution of hemolytic complement in the normal cornea. Arch. Ophthalmol. 99:1430.
31. Mondino, B. J., C. V. Sundar-Raj, and K. J. Brady. 1982. Production of first component of complement by corneal fibroblasts in tissue culture. Arch. Ophthalmol. 100:478.
32. Hazlett, L. D., and R. S. Berk. 1984. Effect of C3 depletion on experimental Pseudomonas aeruginosa ocular infection: histopathological analysis. Infect. Immun. 43:783.
33. King, C. H., P. J. Spagnuolo, and B. M. Greene. 1983. Chemotaxis of human granulocyles toward microfilariae of Onchocerca volvulus. Parasite Immunol. 5:217.
34. Leino, L., and E. M. Lilius. 1992. The up-and down-modulation of immunoglobulin G Fc receptors and complement receptors on activated human neutrophils depends on the nature of activator. J. Leukocyte Biol. 51:157.
35. Ravetch, J. V., and J. P. Kinet. 1991. Fc receptors. Annu. Rev. Immunol. 9:457.
36. de Andres, B., E. Rakasz, M. Hagen, M. L. McCormik, A. L. Mueller, D. Elliot, A. Metwali, M. Sandor, B. E. Britigan, J. V. Weinstock, et al. 1997. Lack of Fc∈ receptors on murine eosinophils: implications for the functional significance of elevated IgE and eosinophils in parasitic infections. Blood 89:3826.
37. Abu-Ghazaleh, R. I., T. Fujisawa, J. Mestecky, R. A. Kyle, and G. J. Gleich. 1989. IgA-induced eosinophil degranulation. J. Immunol. 142:2393.
38. 51Cr-labeled schistosomula of Schistosoma mansoni: mediation by IgG, and inhibition by antigen-antibody complexes. J. Immunol. 118:2230.
39. Tomassini, M., A. Tsicopoulos, P. C. Tai, V. Gruart, A. B. Tonnel, L. Prin, A. Capron, and M. Capron. 1991. Release of granule proteins by eosinophils from allergic and nonallergic patients with eosinophilia on immunoglobulin-dependent activation. J. Allergy Clin. Immunol. 88:365.
40. Forrester, J., A. Dick, P. McMenamin, and W. Lee. 1996. The Eye: Basic Sciences in Practice. W. B. Saunders Company Ltd., London.
41. Trocme, S., C. Hallberg, K. Gill, G. Gleich, S. Tyring, and M. Brysk. 1997. Effects of eosinophil granule proteins on human corneal epithelial cell viability and morphology. Invest. Ophthalmol. Vis. Sci. 38:593.
42. Trocme, S. D., G. J. Gleich, G. M. Kephart, and J. D. Zieske. 1994. Eosinophil granule major basic protein inhibition of comeal epithelial wound healing. Invest. Ophthalmol. Vis. Sci. 35:3051.
43. Smith, J. A. 1994. Neutrophils, host defense, and inflammation: a double-edged sword. J. Leukocyte Biol. 56:672.